New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics

With few effective treatment options for people living with severe multiple sclerosis (MS), the National Institutes of Health (NIH) plans to settle the debate: is a stem cell treatment more effective than the best available biologics?